ABSI
Absci Sees Strong Q4 2025 Performance, Expands Indication Reach
Absci, a leader in the field of artificial intelligence (AI)-powered biotechnology, has reported strong financial and operating results for its fourth quarter and full year ended December 31, 2025. According to Sean McClain, Absci's Founder and CEO, the company had a "strong fourth quarter," with